Division of Cardiology, Pulmonology and Vascular Medicine
Düsseldorf, 40225, Germany
NCT Number: NCT02147223
Epidemiological studies suggest that certain foods rich in flavanols, including cocoa products, red wine, and tea, are associated with decreased cardiovascular mortality and morbidity. Dietary interventional studies have corroborated this finding and showed that flavanols can acutely and after sustained ingestion improve surrogate markers of cardiovascular risk including endothelial function. Endothelial dysfunction is the key event in the development and progression of cardiovascular disease. The aim of the study is to assess sex specific effects of cocoa flavanols on endothelial and vascular function in healthy subjects.
Looking for future studies?
Notify Me50 year and older
All sexes
Interventional
Not applicable
Düsseldorf, 40225, Germany
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Flavanol intervention products (250 mg, 500 mg and 750 mg flavanols)
Calorically, micro- and macronutrient matched control product free of flavanols
Time frame: 2 hours
Time frame: 2 hours
Measured by SphygmoCor
Time frame: 2 hours
Measured by SphygmoCor
Time frame: 2 hours
automatical measurements
Time frame: 2 hours
Measured by HPLC
Time frame: 2 hours
blood/urine samples for safety assessment (haematology, biochemistry, and urinalysis)
Heinrich-Heine University, Duesseldorf
Other
Sex-dependent Effects of Flavanol Metabolism and Absorption on Vascular Status
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03188705
Arterial Occlusive Diseases, Arteriosclerosis
Lancaster, Pennsylvania, United States
View Trial DetailsNCT05882045
Body Weight, Cardiovascular Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT02439775
Cardiovascular Diseases, Hypertension
Huntsville, Alabama, United States
View Trial DetailsNCT05820295
Arrhythmias, Cardiac, Atrial Fibrillation
New York, United States
View Trial Details